Artwork for podcast vP life
#053 Dr Adeel Khan - Stem Cells, Hormones & the Future of Longevity
Episode 5326th April 2026 • vP life • vitalityPRO
00:00:00 00:51:59

Share Episode

Shownotes

Dr Adeel Khan is a Canadian board-certified physician and globally recognised pioneer in regenerative medicine, redefining the future of health, vitality, and recovery. As the founder and CEO of Eterna Health, he works at the forefront of cell-based therapies, specialising in stem cells, peptides, and emerging gene therapies designed to repair tissue, reduce inflammation, and optimise human performance at a cellular level.

Originally trained in sports and musculoskeletal medicine, Dr Khan developed a deep interest in regenerative approaches after seeing the limitations of conventional treatments for injury and chronic disease. This led him to focus on therapies that aim to restore function rather than simply manage symptoms.

Blending clinical practice with innovation, Dr Khan is part of a new wave of physicians pushing medicine toward a more proactive, longevity-focused model—one centred on regeneration, resilience, and optimising human biology.


> During our discussion, you’ll discover:


(00:03:48) How would you define ‘Regenerative’ medicine

(00:05:50) Why is traditional medicine so siloed in its approach

(00:09:08) What is longevity, and what are the biggest needle movers to improve it

(00:14:55) The importance of reducing the load on the immune system

(00:17:36) Stem cells

(00:22:18) How does the immune system respond to stem cells

(00:23:57) How to regulate SASP with senolytics

(00:25:31) Why is HRT overlooked for its longevity benefits

(00:32:58) Why is it important to maintain good sex-hormone levels as we age

(00:35:53) How to start optimising your hormone function

(00:38:05) How to balance out thyroid hormones

(00:42:09) How can gene therapy be used to improve your hormone levels

(00:46:58) HGH replacement therapy

(00:48:40) Klotho and Follistatin

(00:49:32) When will gene therapy become mainstream

(00:50:06) Trevogrumab and Garetosmab


The vP life Podcast is brought to you by vitalityPRO, a supplement company based in the UK that provides you with the latest in health, anti-ageing and longevity supplementation. What makes vitalityPRO unique is that it third-party tests every product batch for quality, purity, heavy metals and other contaminants. vitalityPRO’s mission is simple: provide you with confidence in the quality and effectiveness of your longevity supplements that focus on restoring your cellular health.


To save on your first order, navigate to the home page and sign up for the newsletter to receive 10% off your first order.


Research Links:

Where to find us:

https://vitality-pro.com/

https://www.instagram.com/vitality.pro/?hl=en

https://www.facebook.com/VitalityProSupplements

Transcripts

Speaker:

Welcome to the VP Life Podcast, the show

Speaker:

where we bring you actionable health

Speaker:

advice from leading minds.

Speaker:

I'm your host Rob.

Speaker:

My guest today is Adil Khan, a Canadian

Speaker:

board certified physician and founder of

Speaker:

Eterna Health, working at the forefront

Speaker:

of regenerative medicine using stem

Speaker:

cells, peptides and gene therapies to

Speaker:

repair tissue, reduce inflammation and

Speaker:

optimise human

Speaker:

performance at a cellular level.

Speaker:

Expect to learn how regenerative medicine

Speaker:

is shifting healthcare from symptom

Speaker:

management to true biological repair,

Speaker:

what stem cells, peptides and emerging

Speaker:

therapies are actually doing at a

Speaker:

cellular level and how these therapies

Speaker:

are being used to treat injury, chronic

Speaker:

disease and even influence

Speaker:

the aging process itself.

Speaker:

Now, under the conversations, Dr.

Speaker:

Adil Khan.

Speaker:

Good morning, Dr.

Speaker:

Khan and thank you so much for joining me

Speaker:

on the podcast today.

Speaker:

It's an honour to have you on to discuss

Speaker:

all things longevity

Speaker:

and regenerative medicine.

Speaker:

Now, I can't imagine there are too many

Speaker:

in this space who aren't familiar with

Speaker:

you and your work, but for those who have

Speaker:

been living under a rock, would you mind

Speaker:

introducing yourself and

Speaker:

how you got into this space?

Speaker:

I know you've got quite the story there,

Speaker:

everything from sort of sports medicine

Speaker:

all the way to Tesla.

Speaker:

We've got time, so yeah, if you could

Speaker:

just run us through that.

Speaker:

Yeah, the Tesla thing is I guess

Speaker:

interesting, but because I was a regular

Speaker:

doctor with like a GP, just doing family

Speaker:

medicine and then I started doing sports

Speaker:

medicine and in sports medicine, we are

Speaker:

dealing with chronic injuries, people

Speaker:

with shoulder and shoes, knee, elbow,

Speaker:

whatever, the gamut.

Speaker:

And so people typically do physiotherapy,

Speaker:

they do cortisone injections, which are

Speaker:

just steroid injections to

Speaker:

help with pain and inflammation.

Speaker:

And if that doesn't work, you're usually

Speaker:

sent off to a surgeon or, you know, or

Speaker:

tell or or to take some pain

Speaker:

meds and just live with it.

Speaker:

So I was obviously not

Speaker:

satisfied with that approach.

Speaker:

And so I was kind of like, okay, there

Speaker:

has to be other

Speaker:

options to help these people.

Speaker:

And that's what led me to PRP, which is

Speaker:

platelet rich plasma.

Speaker:

And that's essentially where we just take

Speaker:

your blood, we concentrate the platelets,

Speaker:

which act like little molecules and

Speaker:

signals to help with healing.

Speaker:

And I worked with the guy

Speaker:

who actually pioneered PRP, Dr.

Speaker:

Gallia, he was kind of the first in the

Speaker:

world to do it for like Tiger Woods, a

Speaker:

bunch of other people.

Speaker:

So I was very fortunate to have him as a

Speaker:

mentor, and really learn, let's say the

Speaker:

foundation of regenerative medicine,

Speaker:

which is just the principles of how your

Speaker:

body can heal and cell

Speaker:

biology and all that stuff.

Speaker:

And, then that kind of

Speaker:

led me down this whole road.

Speaker:

Eventually, I got involved in a clinical

Speaker:

trial, using stem cells in

Speaker:

osteoarthritis, and for using body

Speaker:

people's own stem cells.

Speaker:

And we'll obviously go into, you know,

Speaker:

about what stem cells really are.

Speaker:

But, but the point was, this was a

Speaker:

clinical trial, and I was involved in

Speaker:

research, and I kind of just went down

Speaker:

the whole rabbit hole, of trying to find

Speaker:

what's the best for my patient.

Speaker:

And again, this was a lot of this was

Speaker:

driven by curiosity.

Speaker:

And, you know, just because you mentioned

Speaker:

the Tesla thing, I guess I had a little

Speaker:

bit of good fortune, and I

Speaker:

was an early investor in Tesla.

Speaker:

And so because of that, I had a little

Speaker:

bit more, let's say,

Speaker:

leeway and taking risk.

Speaker:

You know, unfortunately, most doctors

Speaker:

can't take much risk, because if they

Speaker:

have to follow, they have to follow their

Speaker:

college guidelines, they

Speaker:

have to stay within the box.

Speaker:

And you know, because

Speaker:

they're scared, right?

Speaker:

They're scared of their license, they're

Speaker:

scared of getting medical legal stuff.

Speaker:

And so I was kind of like, well, you

Speaker:

know, I have some, I have a decent,

Speaker:

decent foundation to kind of go lean back

Speaker:

on if I can't practice

Speaker:

medicine or whatever.

Speaker:

But, but it all it worked out pretty

Speaker:

well, obviously, in the sense that I was

Speaker:

able to build something outside of Canada

Speaker:

and get people coming to me from all over

Speaker:

the world, because I was just very

Speaker:

curious and trying to figure out what's

Speaker:

the best for my patient.

Speaker:

And that I think that's the kind of the

Speaker:

take home message is when you're driven

Speaker:

by curiosity and problem solving, then

Speaker:

you're going to eventually come and do

Speaker:

something that's meaningful, hopefully

Speaker:

for a lot of people.

Speaker:

And that's, that's what led me to the new

Speaker:

cells, which ultimately is what I think

Speaker:

got me a bit more well known in the last

Speaker:

last year or two, because I was the first

Speaker:

doctor in the world outside of Japan to

Speaker:

really start using those cells and

Speaker:

helping a lot of patients with that.

Speaker:

Yeah, that's incredible.

Speaker:

I just like to sort of dive into the sort

Speaker:

of this idea of regenerative medicine a

Speaker:

bit more, it sort of, it tends to fall

Speaker:

under this whole sort of functional sort

Speaker:

of integrated medicine sphere.

Speaker:

And I sort of found that within this

Speaker:

community of physicians, you have doctors

Speaker:

who are who are functional integrated,

Speaker:

but then they sort of tend to sort of

Speaker:

appear one way or the other.

Speaker:

Some of them tend to end up in this sort

Speaker:

of the regenerative space where some of

Speaker:

them tend to end up

Speaker:

in the gut based space.

Speaker:

Obviously, ultimately, of course, it all

Speaker:

ultimately comes down to the same thing

Speaker:

when you're dealing with something

Speaker:

systemically or chronically.

Speaker:

But how would you define regenerative

Speaker:

medicine and sort of maybe differentiated

Speaker:

from the rest of the sort of the

Speaker:

integrated space

Speaker:

because there is definitely,

Speaker:

well, there's a lot of similarity,

Speaker:

there's definitely a lot of differences

Speaker:

there that I think a lot of people tend

Speaker:

to get maybe just a bit confused over.

Speaker:

So yeah, how would you

Speaker:

define that space particular?

Speaker:

Yeah, I mean, look, regenerative medicine

Speaker:

is really about getting

Speaker:

the body to heal itself.

Speaker:

I know that it's a simple definition, but

Speaker:

that's at the core, that's what it is.

Speaker:

It's like, how do we give it the right

Speaker:

signals, the right cells, the right

Speaker:

scaffolds, and in this in the case, and

Speaker:

then so signal cell scaffolds, that's the

Speaker:

easy way to remember it.

Speaker:

Those are the three kind of recipe

Speaker:

ingredients that you need to help your

Speaker:

body to heal itself.

Speaker:

And it's really the biggest difference

Speaker:

though, it's I don't really like the word

Speaker:

functional medicine.

Speaker:

I know some people may not like that.

Speaker:

But I like I like systems biology.

Speaker:

Systems biology is a medical framework in

Speaker:

which we look at the body as a uniform

Speaker:

system, which if one component breaks

Speaker:

down, then it can

Speaker:

affect another component.

Speaker:

So for example, in Alzheimer's, we know

Speaker:

now that there's gut dysbiosis can affect

Speaker:

the brain from a new

Speaker:

inflammatory component.

Speaker:

That's just one example, but there's

Speaker:

millions of examples.

Speaker:

So the point is, the body is

Speaker:

interconnected and treating it as a

Speaker:

fragmented system as a fragmented

Speaker:

specialty based, which is what we set up

Speaker:

in modern medicine, doesn't work.

Speaker:

So yeah, that solid approach.

Speaker:

I suppose we're just going in on a rabbit

Speaker:

hole here off the cuff.

Speaker:

But why do you think I mean, you've been

Speaker:

through the traditional medical training

Speaker:

system, you didn't start off as a

Speaker:

naturopath or anything like that?

Speaker:

Why is medicine still so

Speaker:

siloed in its approach?

Speaker:

I mean, your systems

Speaker:

biology approach just makes sense.

Speaker:

Why do you feel the establishment such

Speaker:

that it is, it's still sort of driving

Speaker:

forward this idea that doctors should be

Speaker:

educated under this sort of in this sort

Speaker:

of very monocular,

Speaker:

especially the one to the better word

Speaker:

state where they just focus on one?

Speaker:

I mean, medicine is slow moving in

Speaker:

general, I think we're the only

Speaker:

profession that probably

Speaker:

still uses fax machines.

Speaker:

So like, that just that just shows you

Speaker:

how sad our profession is sometimes.

Speaker:

And the, but what's happening is, you

Speaker:

know, as an aside, just, you know,

Speaker:

because of all this tech, people, let's

Speaker:

call them tech bros going into the house

Speaker:

space and longevity space, it's it's

Speaker:

forcing doctors to help to either they're

Speaker:

either just going to become outdated, you

Speaker:

know what I mean, and AI and precision

Speaker:

medicine and all this is going to happen.

Speaker:

And then doctors all of a sudden realize

Speaker:

that they don't have a place that

Speaker:

ecosystem, if they don't keep up with

Speaker:

what's happening, right.

Speaker:

And so I think they're gonna a lot of

Speaker:

doctors are gonna be forced to keep up.

Speaker:

But the reason a lot of them are slow to

Speaker:

change is because they can just get away

Speaker:

with doing what

Speaker:

they've always been doing.

Speaker:

And there's no

Speaker:

pressure on them to change.

Speaker:

It's just like a guy is this is like

Speaker:

having a giant government body, right?

Speaker:

Why are governments so slow to get things

Speaker:

done, at least in you know, at least in

Speaker:

like Canada and UK, I think, and a lot of

Speaker:

times it's just because it's like it's

Speaker:

like turning a ship around like a giant

Speaker:

ship, you know, they're not agile and

Speaker:

flexible, they're just,

Speaker:

they're set up inefficiently.

Speaker:

And so even though the approach makes

Speaker:

sense, and it's logical, they want to

Speaker:

probably have like, you know, they

Speaker:

probably want to have decades of clinical

Speaker:

trials before they'll be like, okay, now

Speaker:

we can put this into guidelines, even

Speaker:

though if from a first principles, and

Speaker:

real world evidence

Speaker:

approach, it makes so much sense.

Speaker:

And clearly, the modern

Speaker:

system isn't working either.

Speaker:

So it's like, why not try something else?

Speaker:

But you know, and that's where I guess

Speaker:

the part of the problem with the system

Speaker:

is the way set up is, you know, to go

Speaker:

through this long regulatory framework,

Speaker:

you know, with phase one to phase two

Speaker:

phase three trials and all that costs

Speaker:

like $100 million in North America.

Speaker:

And it just like, who's who which

Speaker:

tactician, there's no one who can afford

Speaker:

to do that with like systems biology, you

Speaker:

know, I mean, because this is biology

Speaker:

isn't like, it's not like a drug, you

Speaker:

know, it's not like,

Speaker:

it's, you can't pat it in it.

Speaker:

And you can't, you can't make millions of

Speaker:

billions of dollars off of it.

Speaker:

So just, it doesn't it

Speaker:

doesn't work with the system.

Speaker:

And so the only other solution is this

Speaker:

kind of grassroots movements, which is

Speaker:

now what's happening, I think, with

Speaker:

people just taking

Speaker:

healthcare into their own hands.

Speaker:

Yeah, no, it is it is

Speaker:

definitely the way forwards.

Speaker:

And I think there's definite, I mean, a

Speaker:

little knowledge for the average person

Speaker:

and little knowledge can definitely be a

Speaker:

dangerous thing, that's sort of the whole

Speaker:

idea of the Dunning Kruger effect.

Speaker:

But yeah, I do think that it yeah, as you

Speaker:

said, it is ultimately the way forwards

Speaker:

and getting people to take ultimately

Speaker:

responsibility for their own health and

Speaker:

then to be to be more educated when

Speaker:

speaking to someone such as yourself

Speaker:

probably is at least

Speaker:

establishes sort of a baseline.

Speaker:

In any case,

Speaker:

before we go on a complete tangent, I

Speaker:

suppose you might as well get back to the

Speaker:

longevity and

Speaker:

regenerative side of things.

Speaker:

But anyway, so obviously,

Speaker:

longevity is a major is a

Speaker:

major thing at the moment.

Speaker:

Everybody's talking about longevity,

Speaker:

everyone's talking about

Speaker:

increasing their health span, etc.

Speaker:

And I'm of course, it's something I'm

Speaker:

interested in, but more so from the

Speaker:

perspective of say, modulating the immune

Speaker:

system in the inflammatory response and

Speaker:

improving cell energetics.

Speaker:

And then definitely restoring and

Speaker:

maintaining hormonal function.

Speaker:

Maybe more so than I am looking at a

Speaker:

single mechanism, or a single sort of

Speaker:

molecular target that

Speaker:

would extend lifespan.

Speaker:

Maybe it's because I'm not a geneticist

Speaker:

or speak, I will speak some very bright,

Speaker:

but I tend to try and focus on the big

Speaker:

picture rather than the minutia.

Speaker:

Now you're obviously in the trenches with

Speaker:

work you do with regards to sort of

Speaker:

helping the patients that you have who

Speaker:

are looking to sort of

Speaker:

improve their longevity.

Speaker:

How do you define longevity?

Speaker:

And then what do you find the biggest

Speaker:

needle movers are in that respect?

Speaker:

Yeah, I mean, I think

Speaker:

you kind of hit on them.

Speaker:

But my definition of longevity really is

Speaker:

just being able to live your highest

Speaker:

quality of life for as long as possible,

Speaker:

which is very simple.

Speaker:

But at the end of the day, what happens,

Speaker:

and this is a real statistic over 90% of

Speaker:

people over age 60 in

Speaker:

America have a chronic disease.

Speaker:

So meaning their quality of life gets

Speaker:

affected, and they can't do the things

Speaker:

that they want to because of their

Speaker:

illnesses or diseases or pain or fatigue

Speaker:

or whatever, maybe mood, depression,

Speaker:

there's so many things

Speaker:

that happen as you get older.

Speaker:

And if you can maintain a high quality of

Speaker:

life for that, as you get in, especially

Speaker:

as you get older, that's really what

Speaker:

longevity is, right?

Speaker:

Being able to live to

Speaker:

your fullest, so to speak.

Speaker:

And that's, that's, that was the whole

Speaker:

thing with my original kind of, let's

Speaker:

say, profession, which was giving getting

Speaker:

people out of chronic pain, because pain

Speaker:

affects people's life a lot, not just

Speaker:

from a purely mental health perspective,

Speaker:

but it can affect their ability to stay

Speaker:

active, which ultimately then affects

Speaker:

their whole health, right?

Speaker:

So because if you're in too much pain,

Speaker:

and you can't stay active, then your

Speaker:

whole body becomes the condition, right?

Speaker:

So that's, that was one of the big things

Speaker:

I realized is that

Speaker:

it's all interconnected.

Speaker:

So you can't just, and that's why you

Speaker:

have to look at the body as a whole.

Speaker:

And so when you're coming to the point of

Speaker:

what moves the needle the most, you kind

Speaker:

of hit them both, which is hormones and

Speaker:

immune, immune system, and the immune

Speaker:

system, the reason immune system is so, I

Speaker:

mean, immunology is

Speaker:

such an interesting topic.

Speaker:

And there's so much, there's so much

Speaker:

stuff going on in right now.

Speaker:

And I'm, I spend most of my extra spare

Speaker:

time reading about immunology these days,

Speaker:

because it's just, that's the hot topic

Speaker:

right now in medicine, I think.

Speaker:

And the reason is because it turns out

Speaker:

the immune system modulates or controls

Speaker:

all these other cells, meaning they

Speaker:

dictate, if the, if your immune cells

Speaker:

send the right signal, you're going to

Speaker:

have good regeneration and good healing,

Speaker:

for example, versus if they send the

Speaker:

wrong signals, and you're going to have

Speaker:

scarring and fibrosis.

Speaker:

So your immune cells, that's just one

Speaker:

example of, but it turns out even with

Speaker:

even cardiovascular disease, there's an

Speaker:

inflammatory component with

Speaker:

plaques and heart disease.

Speaker:

And, and like we talked about

Speaker:

Alzheimer's, neuroinflammation, and so

Speaker:

many different things come

Speaker:

back to the immune system.

Speaker:

So if we can keep your immune health

Speaker:

better in terms of slowing down the aging

Speaker:

process, and that's going to have a huge

Speaker:

impact on your aging.

Speaker:

And that's not just me saying it again,

Speaker:

there's, there's data to back this up.

Speaker:

There's a study in Stanford, which is

Speaker:

really interesting, is

Speaker:

a 17 year long study.

Speaker:

So they looked at seven, like, so almost

Speaker:

two decades, and they track people's

Speaker:

immune system health.

Speaker:

And they found that the immune system

Speaker:

metric that they were using out predicted

Speaker:

their out predicted epigenetic clocks for

Speaker:

predicting mortality or death.

Speaker:

So by up to seven years, so they could

Speaker:

predict more accurately by seven years

Speaker:

more than those epigenetic clocks on, you

Speaker:

know, how long someone's going to live,

Speaker:

which is super interesting.

Speaker:

So what that comes back to is if we can

Speaker:

slow down your immune system aging, we

Speaker:

can likely help you live a healthier,

Speaker:

longer life and, and also

Speaker:

prevent chronic diseases.

Speaker:

And that's, and that's why people have

Speaker:

heard of this whole inflammation concept,

Speaker:

right, chronic inflammation being one of

Speaker:

the biggest drivers.

Speaker:

But so let's come back to why does your

Speaker:

immune system get

Speaker:

older in the first place.

Speaker:

And a lot of this has to do with your

Speaker:

bone marrow micro environment, because

Speaker:

that's where the cells are made, right,

Speaker:

the bone marrow micro environment is

Speaker:

where the stem cells get made, and rest

Speaker:

where your immune cells get made, too.

Speaker:

And so what happens is there's something

Speaker:

called a hematopoietic shift, which means

Speaker:

that more of the, let's say, bad immune

Speaker:

cells are being made, and less of the

Speaker:

good immune cells are

Speaker:

being made as you get older.

Speaker:

And so there's a, there's a

Speaker:

shift that happens with aging.

Speaker:

And so, and then the other thing is your

Speaker:

thymus gland, which is starts to shrink.

Speaker:

Yeah, exactly.

Speaker:

It starts to shrink, and

Speaker:

that trains your T cells.

Speaker:

And that that also doesn't

Speaker:

work as well as you get older.

Speaker:

So the bone marrow and the thymus gland

Speaker:

are two hot areas of research right now,

Speaker:

because if we can do thymus regeneration,

Speaker:

and then if we can keep the bone marrow

Speaker:

micro environment healthy, so that you

Speaker:

can continue to produce a good immune

Speaker:

cells, you can significantly slow down

Speaker:

the aging process, and potentially even

Speaker:

reverse aging, I think.

Speaker:

So that's why there's because there's a

Speaker:

research study that was done in mice, but

Speaker:

it's super interesting, where they were

Speaker:

able to use these engineered stem cells

Speaker:

are called IPSC HSCs.

Speaker:

So they're basically, you know, the

Speaker:

Yamanaka stem cells with hematopoietic

Speaker:

stem cells that were able to reprogram

Speaker:

the bone marrow micro environment, and

Speaker:

significantly slow down

Speaker:

the aging process in mice.

Speaker:

So that just that's just

Speaker:

a very interesting study.

Speaker:

But I think the real world application at

Speaker:

the moment is we do have therapies that

Speaker:

can slow down the immune system aging

Speaker:

process, such as immune cells.

Speaker:

But obviously, I think the I think, you

Speaker:

know, the, the regeneration or repair of

Speaker:

those micro environments and that tissue

Speaker:

in the thymus is going to be a really

Speaker:

interesting area for longevity.

Speaker:

Yeah, no, it's fascinating, especially

Speaker:

when you start looking at some of these,

Speaker:

I don't know what you think of

Speaker:

bioregulators that are supposedly have

Speaker:

been shown to help regenerate the thymus.

Speaker:

Specifically on the immune system,

Speaker:

though, what do you feel about this idea

Speaker:

of the fact that the immune system is

Speaker:

going to for the most part is going to be

Speaker:

triggered by a huge number of

Speaker:

environmental factors, anything from

Speaker:

mold, microplastics, etc, that are then

Speaker:

sort of going to drive up this

Speaker:

inflammatory response that was then going

Speaker:

to result in the development of the

Speaker:

inflammation specifically.

Speaker:

Do you think that I suppose part of the

Speaker:

picture here is looking at ways to sort

Speaker:

of reduce that that load on the body so

Speaker:

as to reduce the 100%

Speaker:

in fact, there was a study the research

Speaker:

on if you look at the research on

Speaker:

multiple sclerosis, which is an

Speaker:

autoimmune condition, it's almost it's

Speaker:

every like they found like something like

Speaker:

I can't remember the exact number, but

Speaker:

it's really high, like 95% or something

Speaker:

was linked to EBP, like so almost

Speaker:

everyone who has MS has EBP, which what

Speaker:

does that show you that shows you that's

Speaker:

probably the actual cause of MS, you

Speaker:

know, that's like like like likely the

Speaker:

causative or most important risk factor.

Speaker:

And so chronic infections and chronic

Speaker:

toxins in the body, microplastics,

Speaker:

pesticides, all these things play a role

Speaker:

in kind of hijacking our immune system

Speaker:

and making it in balance or dysregulated.

Speaker:

So that's why we know this.

Speaker:

I mean, the medicines know this for a

Speaker:

while too, as they

Speaker:

call it molecular mimicry.

Speaker:

That's kind of like

Speaker:

the medical term, right?

Speaker:

And so essentially, just meaning like

Speaker:

these toxins are kind of making your body

Speaker:

think that the tissue that's healthy is

Speaker:

actually unhealthy, and

Speaker:

then they start attacking it.

Speaker:

And so why is that tissue presenting as

Speaker:

an unhealthy tissue in the first place is

Speaker:

because there's intracellular pathogens

Speaker:

inside of that tissue, or there's

Speaker:

microplastics, or there's all this

Speaker:

garbage that's

Speaker:

building up inside the cell.

Speaker:

And then your immune

Speaker:

system's like, hey, what the heck?

Speaker:

What's wrong with you?

Speaker:

And then it starts attacking it.

Speaker:

And so then the doctors are just

Speaker:

suppressing the immune system.

Speaker:

They're not going- Biologics.

Speaker:

Yeah, which is biologics or

Speaker:

immunosuppressants or f-prednisone or

Speaker:

monoclonal antibodies.

Speaker:

They're not really

Speaker:

fixing the problem, right?

Speaker:

Which is fine.

Speaker:

We didn't really understand all the

Speaker:

science before, but I think now it's

Speaker:

becoming much more clearer.

Speaker:

And so what we do is we

Speaker:

try to remove the bad.

Speaker:

And there's all these technologies out

Speaker:

there that can do that pretty effectively

Speaker:

now with, there's something called in-use

Speaker:

phoresis, which is in Europe.

Speaker:

It's been around for a while and they've

Speaker:

had, they have data showing, they've

Speaker:

helped autoimmune patients and they can

Speaker:

remove microplastics

Speaker:

and all these things.

Speaker:

And you can combine that with other

Speaker:

therapies to kind of

Speaker:

reset the immune system.

Speaker:

So that's the whole idea.

Speaker:

Yeah.

Speaker:

And where do stem cells

Speaker:

start to fit in this picture?

Speaker:

I suppose you might, it's a good sort of

Speaker:

juncture to start talking about stem

Speaker:

cells in particular with

Speaker:

regards to immune system.

Speaker:

Of course, I think most people view stem

Speaker:

cells purely from the sort of tissue

Speaker:

regenerative standpoint.

Speaker:

I think that is what comes across in

Speaker:

social media the most in any case.

Speaker:

You take stem cells, whether it's, yeah,

Speaker:

whatever form it is, whether it's an

Speaker:

autologous stem cell, such as, I believe

Speaker:

that's PRP, something like that, if I've

Speaker:

got that right, or some sorts of

Speaker:

harvested stem cell.

Speaker:

And most people sort of associate that

Speaker:

again, whether you've got some sort of

Speaker:

cartilage degeneration on your knee or

Speaker:

some sort of aesthetic procedure.

Speaker:

But how are you utilizing these therapies

Speaker:

in these cells to then sort of modulate

Speaker:

the immune response in particular?

Speaker:

Yeah.

Speaker:

So the first problem is, I always have to

Speaker:

get a little bit of a history lesson,

Speaker:

unfortunately, because the first problem

Speaker:

is the word stem cells,

Speaker:

mesenchymal stem cells.

Speaker:

And mesenchymal is kind of like an

Speaker:

embryological term that all these stem

Speaker:

cell clinics that are out there, they're

Speaker:

using what are called mesenchymal stem

Speaker:

cells, which are either derived from fat,

Speaker:

bone marrow, or umbilical

Speaker:

cord tissue or placenta tissue.

Speaker:

Those are perinatal tissue, those are

Speaker:

typically the three most common sources.

Speaker:

And so the problem is the guy who coined

Speaker:

that term in 1992 wrote a paper in 2017

Speaker:

saying that we need to rename it to

Speaker:

medicinal signaling cells.

Speaker:

His name is Dr.

Speaker:

Arnold Kaplan.

Speaker:

And so essentially he was saying that he

Speaker:

named them wrongly because

Speaker:

they are not true stem cells.

Speaker:

They're just not able to regenerate

Speaker:

tissue, like you were saying.

Speaker:

What they do is they do something called

Speaker:

paracrine signaling, which is a signal

Speaker:

and they modulate their environment,

Speaker:

which can still reduce inflammation and

Speaker:

still be helpful, but it's not true

Speaker:

regenerative, which is what people are

Speaker:

looking for and what people are hoping

Speaker:

for with these treatments.

Speaker:

And that was a problem with all these

Speaker:

stem cell clinics and why most of these

Speaker:

stem cell clinics, to be

Speaker:

honest, are scam in a sense.

Speaker:

And a lot of them are

Speaker:

just marketing and hype.

Speaker:

And there's just a lot of

Speaker:

misinformation out there.

Speaker:

And that's also why a lot of mainstream

Speaker:

doctors don't like it because it's like

Speaker:

these clinics are offering these things

Speaker:

which aren't true stem cells.

Speaker:

And that's still a problem because all

Speaker:

these clinics are saying we do stem cell

Speaker:

injections, but they're not

Speaker:

doing stem cell injections.

Speaker:

They're doing signaling molecule

Speaker:

injections or what are, or the other,

Speaker:

other technical name is what's called a

Speaker:

committed progenitor cell, which means

Speaker:

it's already committed

Speaker:

to a certain cell lineage.

Speaker:

It's not able to differentiate into all

Speaker:

the different types of cell types.

Speaker:

So what is a true stem cell?

Speaker:

A true stem cell, it can

Speaker:

turn into any cell in the body.

Speaker:

What's called a pluripotent stem cell.

Speaker:

And so that's, that's, but the issue with

Speaker:

pluripotent stem cells has historically

Speaker:

has been the risk of tumors or cancer

Speaker:

because they could not

Speaker:

turn into tumors as well.

Speaker:

Right.

Speaker:

And that, that's the kind of the big

Speaker:

breakthrough with these new cells, which

Speaker:

is what we're using because they're

Speaker:

pluripotent, meaning they can turn into

Speaker:

any cell in the body, but

Speaker:

they're non-tumorogenic.

Speaker:

So they have the best of both worlds.

Speaker:

So they can not only differentiate into

Speaker:

cartilage or heart or liver.

Speaker:

They've been shown to generate into new

Speaker:

bone, like new brain

Speaker:

tissue to like neural neurons.

Speaker:

So they can turn into anything you need

Speaker:

them to, but there's no risk of cancer.

Speaker:

And in fact, there's research suggests

Speaker:

that they may even

Speaker:

suppress cancer growth.

Speaker:

So it's really, really promising in terms

Speaker:

of their future of, for so

Speaker:

many different applications.

Speaker:

But to come back to your question, what

Speaker:

the immune cells do more than anything is

Speaker:

they help modulate your immune system.

Speaker:

And this has been shown in, in clinical

Speaker:

clinical research, but also with some of

Speaker:

the evidence that we published, we just

Speaker:

published some, we

Speaker:

just published a paper.

Speaker:

I mean, it's just a few cases, but we

Speaker:

used, you know, we use this generation

Speaker:

lab, which is like systems biology aging

Speaker:

test, and essentially measures 19

Speaker:

different organ systems.

Speaker:

And we're able to show like, with just

Speaker:

one or two infusions of the immune cells,

Speaker:

you can see like 10, up to 10 years of

Speaker:

reversal of biological

Speaker:

age in the immune system.

Speaker:

And then you can see

Speaker:

significant slowing down of that.

Speaker:

And then you see the inflammatory

Speaker:

response completely become blunted.

Speaker:

So there's a shift that happens after the

Speaker:

immune cells, which

Speaker:

is really interesting.

Speaker:

And the whole idea is that we combine it

Speaker:

with that blood cleaning technology.

Speaker:

So for, let's say someone who has an

Speaker:

autoimmune condition or dealing with

Speaker:

chronic infections, you know, whether

Speaker:

that's mold or lime or whatever, then one

Speaker:

of the things you can do is you can

Speaker:

remove all the bad stuff using that

Speaker:

technology, like the endocerases, and

Speaker:

then you can put in the new cells.

Speaker:

So it's like you're, you're preparing the

Speaker:

soil before you plant the seeds.

Speaker:

And then you can also you can, of course,

Speaker:

we touch on hormones a little bit, you

Speaker:

can also optimize our hormones using, you

Speaker:

know, functional genomics and blood work

Speaker:

and all that stuff to really look at

Speaker:

their hormone metabolism, and then figure

Speaker:

out and make an

Speaker:

individualized plan for them.

Speaker:

So that way, you're kind of like

Speaker:

optimizing the hormones, you're

Speaker:

optimizing their body

Speaker:

before you put in these cells.

Speaker:

And that's really what

Speaker:

leads to good results.

Speaker:

Yeah, definitely.

Speaker:

And I'd love to come

Speaker:

back to homes in a moment.

Speaker:

Mechanistically, what is going on, I

Speaker:

suppose, at this, at the level of the

Speaker:

immune system, when you're introducing

Speaker:

these stem cells, is there sort of an

Speaker:

increase in natural killer cell activity?

Speaker:

No, it's actually a Treg and TH17.

Speaker:

It's increasing the balance of that.

Speaker:

And then so basically

Speaker:

more T regulatory cells.

Speaker:

And then the other thing is it's

Speaker:

increasing macro, what's called

Speaker:

macrophage polarization.

Speaker:

So shifting the macrophage.

Speaker:

And one to two.

Speaker:

Yeah, exactly.

Speaker:

Yeah.

Speaker:

So those are two of the biggest ones.

Speaker:

But then there's also the other thing is,

Speaker:

is helping with what's called SASP,

Speaker:

senescence associated

Speaker:

secretinative phenotype.

Speaker:

So which is essentially one of the

Speaker:

hallmarks of aging, and it helps to

Speaker:

reprogram those cells to have a different

Speaker:

gene expression profile that's more anti

Speaker:

inflammatory, as opposed to the pro

Speaker:

inflammatory senescent profile.

Speaker:

And it actually clears out this is the

Speaker:

coolest thing about new cells.

Speaker:

New cells have what's

Speaker:

called phagocytosis.

Speaker:

So they actually eat the day so let's say

Speaker:

they go to your heart, and there's a

Speaker:

damage, there's damaged heart cells in

Speaker:

there that are senescent that are old and

Speaker:

your body can't clear them out, the new

Speaker:

cells will actually eat them.

Speaker:

And then they'll use a cellular machinery

Speaker:

to turn to a new heart cell that's

Speaker:

functionally better and works better.

Speaker:

Yeah.

Speaker:

And for the audience, that whole process

Speaker:

of phagocytosis forms into this what's

Speaker:

been sort of popularized as this idea of

Speaker:

autophagy upregulating the sort of the

Speaker:

cell recycling process

Speaker:

within a specific target tissue.

Speaker:

That's fascinating, especially the

Speaker:

ability for it to sort of help balance

Speaker:

out that TH17 response as well.

Speaker:

I mean, I know that's also mediated by

Speaker:

Holman specifically, which we can talk

Speaker:

about in a minute things

Speaker:

like excess of estrogen, etc.

Speaker:

Wow.

Speaker:

And then, yeah, I apologize to everyone

Speaker:

who's listening, I might get we might get

Speaker:

a little technical here.

Speaker:

What do you how are you then regulating

Speaker:

the SASP on the back end of that with

Speaker:

regards to looking at compounds like your

Speaker:

your senolytics, everything from your

Speaker:

natural phi-setins to your pharmaceutical

Speaker:

candidates like dastinib.

Speaker:

Are you utilizing any of those compounds

Speaker:

to then sort of clean up the sort of the

Speaker:

leftovers senescent cells?

Speaker:

We use there's a couple there's a company

Speaker:

called qualia, which

Speaker:

makes a senolytic supplement.

Speaker:

So we've been using that one.

Speaker:

And I don't know if there's anything, you

Speaker:

know, I'm not I'm not a super expert as

Speaker:

you are on supplements.

Speaker:

So there might be

Speaker:

something better out there.

Speaker:

But that's the one I've been using.

Speaker:

And then the other other interesting

Speaker:

intervention from a cellular therapy

Speaker:

perspective are NK cells.

Speaker:

So allogeneic natural natural killer

Speaker:

cells act like a

Speaker:

sponge for senescent cells.

Speaker:

So that's another if you you know, for

Speaker:

for older people, especially, excuse me,

Speaker:

for older people, especially, you can do

Speaker:

NK cells prior to the mucal infusion,

Speaker:

because the NK cells help to reduce that

Speaker:

SASP microenvironment and help to clear

Speaker:

out some of the senescent cells before

Speaker:

you put in the mucal.

Speaker:

I did not know that.

Speaker:

I believe that IP6 phosphate just doesn't

Speaker:

offer you probably aware of this is also

Speaker:

going to increase in activity within this

Speaker:

within well within the

Speaker:

immune system as well.

Speaker:

That's anositol 6 phosphate.

Speaker:

So that's also an interesting one that's

Speaker:

been shown to increase.

Speaker:

I assume it do you mean natural killer

Speaker:

cell activity there?

Speaker:

Yeah, okay.

Speaker:

No, that's an that's one that's also got

Speaker:

shown to be quite

Speaker:

effective at helping to increase.

Speaker:

Yeah, NK cell activity.

Speaker:

In any case, I think we're getting a

Speaker:

listen to the weeds here.

Speaker:

Dr.

Speaker:

Kahn, I'd love to maybe pivot and to talk

Speaker:

about hormones a little

Speaker:

bit now if that's okay.

Speaker:

Specifically, as they again, as they

Speaker:

pertain to these longevity outcomes.

Speaker:

Now, like you,

Speaker:

I follow bodybuilding quite closely.

Speaker:

And, and to be honest, I think maybe

Speaker:

outside of individual societies yourself,

Speaker:

and a lot of these sort of

Speaker:

institutionalized academics, their cohort

Speaker:

of individuals that definitely I find

Speaker:

fascinating because,

Speaker:

for the most part, I think they

Speaker:

understand human biology better than

Speaker:

better than most, especially your sorts

Speaker:

of your newer guys,

Speaker:

like, like your Dean St.

Speaker:

Marty, your vigorous Steve's, etc.

Speaker:

I mean, they, it's in their best interest

Speaker:

to understand the human biology because

Speaker:

ultimately, that's the way

Speaker:

you get the body thereafter.

Speaker:

Now, I'm not saying that what these guys

Speaker:

do is necessarily the

Speaker:

best for longevity outcomes.

Speaker:

I mean, yeah, yes, your tremolones, your

Speaker:

methylated testosterone are great for

Speaker:

throwing on slabs of tissue.

Speaker:

But from a systemic standpoint, they're

Speaker:

just going to

Speaker:

increase oxidative stress and

Speaker:

drive up androgenicity and create all

Speaker:

manner of health

Speaker:

issues related on the line.

Speaker:

The proper use of HRT, however, I think

Speaker:

does interest me as longevity aid,

Speaker:

especially in the society we have today,

Speaker:

where people's levels of hormones for a

Speaker:

lot of the reasons we've already

Speaker:

discussed are just lower than ever.

Speaker:

Now, of course,

Speaker:

yeah, endocrine disruptors

Speaker:

lack of sleep, the list goes on.

Speaker:

And again, as you said earlier, these

Speaker:

environmental toxins, yeah,

Speaker:

two times, so your molds, etc.

Speaker:

Now, I'd love to discuss maybe some of

Speaker:

the nuances of HRT and both men and women

Speaker:

from a longevity perspective.

Speaker:

But why do you think, but before we get

Speaker:

there, why do you think it's often

Speaker:

overlooked as a longevity

Speaker:

candidate or a longevity aid?

Speaker:

I mean, especially when you start looking

Speaker:

at the ITP, most people are just again,

Speaker:

looking at these single molecules to try

Speaker:

and sort of, yeah, improve longevity

Speaker:

outcomes, improve health span, whether

Speaker:

it's astaxanthin, or the latest senolytic

Speaker:

or whatever, but very few people are

Speaker:

seemingly, again, we've discussed this

Speaker:

already, the immune system, but focusing

Speaker:

on the endocrine

Speaker:

system, the hormone system.

Speaker:

Do you have a feeling as

Speaker:

to why that is specifically?

Speaker:

Well, I think part of the problem is

Speaker:

there wasn't personalization and

Speaker:

understanding how to

Speaker:

restore the whole access.

Speaker:

Like, for example, it's kind of, it was

Speaker:

very primitive, and it still is for a lot

Speaker:

of people, which is basically like, oh,

Speaker:

you have low testosterone, so take some

Speaker:

testosterone, you have low estrogen, so

Speaker:

take some estrogen, but there, but again,

Speaker:

it's, it's kind of looking at the whole

Speaker:

body and asking yourself, okay, does this

Speaker:

make sense for this picture?

Speaker:

Or why is it low in the first place?

Speaker:

Or is there something we can do from a

Speaker:

systems biology approach to get your own

Speaker:

body to produce more of it?

Speaker:

And especially for a young, like you

Speaker:

said, younger and younger people are

Speaker:

presenting with low testosterone.

Speaker:

That's not normal, you know, and there's

Speaker:

people in their 20s and 30s going on TRT.

Speaker:

And that, that, that to me is a bit of a

Speaker:

problem, because then you're not, you're

Speaker:

not going to the root cause necessarily,

Speaker:

which could be the adrenal access, and it

Speaker:

could be because of microplastics and the

Speaker:

endocrine, it could be so many different

Speaker:

things that you want to look at and see

Speaker:

if you can kind of restart or re jump the

Speaker:

system, so to speak.

Speaker:

And there's, and I think that's where

Speaker:

kind of functional

Speaker:

genomics was really interesting.

Speaker:

We have a doctor, Dr.

Speaker:

Mansoor Muhammad.

Speaker:

He's a, he's kind of like the guy who

Speaker:

pioneered, I would say he has, he's the

Speaker:

only one I know, as far as I know, that

Speaker:

has this insight into looking at your

Speaker:

specific genes that

Speaker:

affect hormone metabolism.

Speaker:

Because obviously when you do these

Speaker:

genetic tests, like, you know, from these

Speaker:

DNA companies, they look at there's

Speaker:

thousands of genes and it's not very, it

Speaker:

just gives you a big report and it

Speaker:

doesn't really give you

Speaker:

a lot of good insight.

Speaker:

You know what I mean?

Speaker:

It's very generic.

Speaker:

Whereas Dr.

Speaker:

Mansoor, what he does is he says, no, I

Speaker:

figured out which genes to look at

Speaker:

specifically to optimize your health and

Speaker:

longevity and not just hormonal ones, but

Speaker:

then there's other important ones too,

Speaker:

obviously like methylation

Speaker:

and other things like that.

Speaker:

But so he does a very tailored approach.

Speaker:

And that's what we use personally to

Speaker:

optimize people's hormones.

Speaker:

Because then he can say, okay, look, your

Speaker:

estrogen metabolism or your progesterone

Speaker:

metabolism is faster than it should be.

Speaker:

And therefore, this is like a deficiency

Speaker:

that you're going to or you're going to

Speaker:

have, you know, because of that you have

Speaker:

this X deficiency and this

Speaker:

is what you need to take.

Speaker:

So he can give you a much more

Speaker:

personalized and specific plan than just

Speaker:

kind of being like looking at your blood

Speaker:

work and telling you based off your

Speaker:

genetics, maybe why your hormones, you

Speaker:

know, are presenting the way they are.

Speaker:

Yeah, definitely.

Speaker:

Is his company the DNA company?

Speaker:

Have I got that right?

Speaker:

He was, long story, he

Speaker:

was part of the DNA company.

Speaker:

He was the founder, he was actually the

Speaker:

founder of that company.

Speaker:

He was his chief scientific.

Speaker:

He was the one who

Speaker:

created all their products.

Speaker:

But then he ended up leaving

Speaker:

and started his own company.

Speaker:

And now his company is

Speaker:

called the PhD clinic.

Speaker:

Okay, no, I have to check that out.

Speaker:

No, it's another rabbit hole.

Speaker:

But yeah, no, I love the

Speaker:

fact that you brought that up.

Speaker:

I think, and in a minute, we will have to

Speaker:

talk about the importance

Speaker:

of hormones and longevity.

Speaker:

But yeah, I think people especially women

Speaker:

who put on to HRT, genes

Speaker:

aren't taken into account.

Speaker:

And I think another great test is, as

Speaker:

you're probably well aware of, is the

Speaker:

Dutch test in that respect.

Speaker:

And just being able to identify how

Speaker:

effectively someone is going to

Speaker:

metabolize a certain hormone before it's

Speaker:

introduced to their body, I think is very

Speaker:

important, especially for women sort of

Speaker:

transitioning or going into menopause,

Speaker:

where maybe they've not actually ever

Speaker:

done any sort of hormonal testing as a

Speaker:

baseline previously.

Speaker:

So you don't have an idea of how

Speaker:

effective of where that sort of estrogen

Speaker:

baseline necessarily is.

Speaker:

Now, of course, you can

Speaker:

give someone testosterone.

Speaker:

And for the most part, that's relatively

Speaker:

easy to control in terms of systemic

Speaker:

outcomes, but in terms

Speaker:

of a side effect, sorry.

Speaker:

But when you start looking at estrogen,

Speaker:

and giving it to someone specifically,

Speaker:

and you're not aware of how well they're

Speaker:

going to methylate or break it down,

Speaker:

you're not aware of sort of first and

Speaker:

second phase detoxification, in that

Speaker:

respect, I think it

Speaker:

starts to get quite messy.

Speaker:

And you can potentially start to trigger

Speaker:

the development of certain cancers,

Speaker:

especially where there's just a buildup

Speaker:

of estrogen in the body over time.

Speaker:

Obviously, your estrogen sensitive

Speaker:

cancers specifically.

Speaker:

So yeah, that's amazing.

Speaker:

I love the fact that you take that

Speaker:

approach and you're looking at it from

Speaker:

more than just a serum

Speaker:

blood work standpoint.

Speaker:

In any case,

Speaker:

off track again, this is...

Speaker:

That's interesting.

Speaker:

Yeah, because most people, I mean, that's

Speaker:

what's offered to 99%

Speaker:

of people still, right?

Speaker:

So people need to know that there's

Speaker:

something more sophisticated out there.

Speaker:

It's just educating the public.

Speaker:

Yeah, no, definitely.

Speaker:

And I think it just goes to the sort of

Speaker:

whole cookie cutter approach with hormone

Speaker:

therapy, and why it

Speaker:

fails to so many people.

Speaker:

Obviously, in the UK, I'm sure familiar

Speaker:

with the system we have here, everybody

Speaker:

just gets the overall patch, obviously,

Speaker:

women in this respect, and then all of a

Speaker:

sudden, they're bloated, depressed, and

Speaker:

they have no clue why, but they're on

Speaker:

HRT, why is it not working well?

Speaker:

You are now estrogen dominant, have no

Speaker:

progesterone or testosterone, and you

Speaker:

wonder why you feel miserable as hell.

Speaker:

In any case,

Speaker:

again, apologies to everyone listening,

Speaker:

we've got straight into the weeds.

Speaker:

But Dr.

Speaker:

Kahn, I think it would be great if we

Speaker:

could maybe just take a quick step back

Speaker:

and talk about some of the importance of

Speaker:

the importance of hormones in longevity.

Speaker:

Now, I think when people think of, again,

Speaker:

think of hormones, it's just the sex

Speaker:

hormones that they think about.

Speaker:

Of course, there are dozens of hormones.

Speaker:

But specifically,

Speaker:

your testosterone, your estrogen, your

Speaker:

progesterone, your sex hormones, why is

Speaker:

it important to maintain

Speaker:

levels of those hormones as we age?

Speaker:

What are their sort of fundamental roles

Speaker:

in helping someone to age,

Speaker:

quote unquote, gracefully?

Speaker:

Well, I think we know with obviously with

Speaker:

testosterone, but also estrogen and

Speaker:

progesterone having the right balance,

Speaker:

they all they relate to muscle mass, bone

Speaker:

density, heart health, brain health.

Speaker:

So meaning if you have low testosterone,

Speaker:

you're at increased risk of depression.

Speaker:

In fact, there was a talk I attended

Speaker:

once, where they said the most common

Speaker:

reason for a Prozac prescription in men

Speaker:

is low testosterone.

Speaker:

And because a lot of doctors, I mean, now

Speaker:

there's obviously

Speaker:

more awareness about it.

Speaker:

But 10 years ago, there wasn't that

Speaker:

awareness to check

Speaker:

testosterone routinely.

Speaker:

I mean, I don't think

Speaker:

it's still done routinely.

Speaker:

But you know, at least there's more

Speaker:

awareness to understand that, hey, maybe

Speaker:

you have low mood, and maybe you're not

Speaker:

feeling very good

Speaker:

because of your hormones.

Speaker:

So more people are at

Speaker:

least thinking about that.

Speaker:

And then I think, you know, with estrogen

Speaker:

and progesterone is kind of the same

Speaker:

thing, we know how

Speaker:

protected they are for the body.

Speaker:

And finding the right balance is the key.

Speaker:

It's not about like you said, it's not

Speaker:

about having high levels necessarily,

Speaker:

it's about achieving

Speaker:

balance of those hormones.

Speaker:

And that balance can be a little bit

Speaker:

different for everyone too, I think.

Speaker:

So that's really where, you know, I think

Speaker:

for musculoskeletal health, especially,

Speaker:

that's really, I think the important

Speaker:

thing when it comes to longevity because

Speaker:

sarcopenia and low bone density become,

Speaker:

which is osteoporosis, become a big

Speaker:

problem for women, especially as they get

Speaker:

into their 50s and 60s.

Speaker:

And it only accelerates and then becomes

Speaker:

a big problem for men too, as they get

Speaker:

into their 60s, and they

Speaker:

can't put on muscle mass.

Speaker:

So if there's something, you know, we can

Speaker:

do to combat that from a hormonal

Speaker:

environment, then that's going to be, you

Speaker:

know, obviously ideal.

Speaker:

And I think, I think, you know,

Speaker:

obviously, the thyroid, the thyroid

Speaker:

hormones are also important, those are

Speaker:

just the sex hormones, but thyroid, I'm

Speaker:

sure people know that's

Speaker:

related to metabolism.

Speaker:

And, you know, it can, if you have a

Speaker:

thyroid, it can make you sluggish and

Speaker:

weight gain and all this other stuff.

Speaker:

But it can also affect importantly for

Speaker:

us, it can, there's studies showing that

Speaker:

if the thyroid levels are low, it can

Speaker:

affect the micro environment of the stem

Speaker:

cells to do their job effectively.

Speaker:

So that's one of the

Speaker:

reasons we look at hormones too.

Speaker:

And we want them optimized because it can

Speaker:

affect the stem cells

Speaker:

ability to do their job.

Speaker:

Yeah, no, I'd love to get into the

Speaker:

thyroid the minute because again,

Speaker:

something that I think a lot of people

Speaker:

sort of overlook is that if you've got

Speaker:

poor circulating levels of T3, the active

Speaker:

thyroid hormone, it's going to alter, I

Speaker:

believe, its star expression within the

Speaker:

mitochondria and the ability for the

Speaker:

mitochondria to actually

Speaker:

produce energy as well.

Speaker:

In any case, how do you, as a physician,

Speaker:

of course, start to look to help people

Speaker:

optimize thyroid, not excuse me, this

Speaker:

hormone function off the bat, obviously,

Speaker:

you're taking a functional

Speaker:

sort of genomic view of it.

Speaker:

And you're obviously including a lot of

Speaker:

blood work and, and

Speaker:

other metrics in this regard.

Speaker:

But are you sort of starting off with

Speaker:

sort of prohormones, things like

Speaker:

Pringnelen and DHE to start off with just

Speaker:

to see if you can increase

Speaker:

someone's natural sort of

Speaker:

Yeah, that's my approach.

Speaker:

Obviously, everyone's

Speaker:

different with this stuff.

Speaker:

But I'm always of the

Speaker:

logic that if we can get your system to

Speaker:

work better on its own,

Speaker:

why don't we try that first.

Speaker:

And that's where peptides and you know,

Speaker:

you mentioned bioregulators, you know, my

Speaker:

regulators, I don't know how great the

Speaker:

evidence is on that, to be honest, and I,

Speaker:

you know, and I've heard mixed things,

Speaker:

but I have seen, I've seen it helpful in

Speaker:

certain cases, very, bioregulators are

Speaker:

very hit or miss in my experience.

Speaker:

But you know, peptides tend to be a bit

Speaker:

more consistent, for example, something

Speaker:

called kisspeptin, an ACG, which is, you

Speaker:

know, basically can stimulate your LH and

Speaker:

your own body to produce more

Speaker:

testosterone on its own.

Speaker:

And that you can, like you said, you can

Speaker:

combine that with precursors like

Speaker:

pregnant alone and DHEA.

Speaker:

And then, you know, you can really get

Speaker:

your own access going again and get your

Speaker:

own body to produce more testosterone.

Speaker:

But I think so to me,

Speaker:

that's always my first approach.

Speaker:

Same thing with, you know, even with

Speaker:

estrogen, estrogen metabolism, for

Speaker:

example, there's research showing that,

Speaker:

you know, the vaginal microbiome and the

Speaker:

gut microbiome can

Speaker:

affect estrogen metabolism.

Speaker:

So meaning your estrogen, you can become

Speaker:

estrogen dominant because of gut

Speaker:

dysbiosis and because

Speaker:

of vaginal dysbiosis.

Speaker:

And so there's these next generation

Speaker:

supplements now, probiotic supplements,

Speaker:

basically, which help to restore the

Speaker:

flora, which have been shown to help to

Speaker:

restore the balance in

Speaker:

the hormones as well.

Speaker:

Yeah, that's fascinating.

Speaker:

I'll have to do a bit of a deeper dive

Speaker:

into that, especially sort

Speaker:

of the vaginal microbiome.

Speaker:

Yeah, check it.

Speaker:

There's a supplement called Get Happy,

Speaker:

it's from Germany, you know, how to name

Speaker:

Get Happy, but it's from Germany.

Speaker:

And it's a vaginal microbiome supplement,

Speaker:

but it's been, that's

Speaker:

basically what it does.

Speaker:

And they have the research to kind of,

Speaker:

they have like, a lot of research to kind

Speaker:

of back up what they're saying.

Speaker:

Yeah, I'll definitely dig into that.

Speaker:

Thank you.

Speaker:

And then just to sort of, I suppose,

Speaker:

touch on the thyroid piece specifically.

Speaker:

Now, obviously, in aging populations, the

Speaker:

thyroid is naturally going to decline,

Speaker:

you sort of see that that transient rise

Speaker:

in TSH as an individual gets older, and

Speaker:

then I suppose, naturally, sort of lower

Speaker:

levels of the circulating thyroid

Speaker:

hormones, T3, T4, T3, T3, T4, etc.

Speaker:

Maybe, that might be a bit of a technical

Speaker:

question, I suppose, but where do you

Speaker:

sort of, how do you start to deal with

Speaker:

some of these hormones, again, from a

Speaker:

long, well, thyroid hormones from a

Speaker:

longevity perspective, especially taking

Speaker:

into account that as one ages, there's

Speaker:

going to be a sort of a decrease in these

Speaker:

three levels of

Speaker:

circulating thyroid, of course.

Speaker:

And I only mention that because I assume

Speaker:

when you look at it from a sort of a

Speaker:

physiology standpoint, there has to be a

Speaker:

reason for thyroid declining as one ages.

Speaker:

Now, obviously, if you ramp up thyroid

Speaker:

activity too much, you're going to

Speaker:

actually end up sort of burning through

Speaker:

that stem cell pull, I think

Speaker:

I'm correct in saying that.

Speaker:

So how do you find that sort of that

Speaker:

happy balance between helping somebody

Speaker:

sort of maintain optimal thyroid function

Speaker:

so that they aren't brain fog depressed,

Speaker:

overweight, and moody versus not in this

Speaker:

sort of hypercatabolic state where

Speaker:

they're burning through the excess

Speaker:

cortisol stem cells, etc.

Speaker:

Do you find that people generally need

Speaker:

replacement as they sort of get older?

Speaker:

Or is that sort of very individual?

Speaker:

Well, yeah, I mean, you're coming back to

Speaker:

the whole idea, right?

Speaker:

The thyroid is kind of like the metabolic

Speaker:

engine of the cells.

Speaker:

And if it's not functioning properly,

Speaker:

then your whole metabolic activity and

Speaker:

how your mitochondria work and everything

Speaker:

in the cells will be affected.

Speaker:

And so that's why it's such a crucial

Speaker:

hormone to have optimized.

Speaker:

But the way I look at it is there's, for

Speaker:

example, there's a lot of co factors such

Speaker:

as selenium, which is such an easy thing

Speaker:

to supplement with or eat Brazil nuts,

Speaker:

which can be an important factor to help

Speaker:

with increasing your own body's

Speaker:

production of thyroid and

Speaker:

making it work more efficiently.

Speaker:

And then there's something called reverse

Speaker:

T3, which is another way to kind of look

Speaker:

at and interpret that, hey, maybe your

Speaker:

body's under a lot of stress and then get

Speaker:

cortisol and adrenal dysregulation.

Speaker:

I don't really like

Speaker:

the word adrenal fatigue.

Speaker:

But dysregulation is the more appropriate

Speaker:

word, I think, which is, you know, when

Speaker:

your cortisol is low, it's high, and when

Speaker:

it's high, it's low.

Speaker:

And that's what

Speaker:

happens to a lot of people.

Speaker:

So they don't have that spike in cortisol

Speaker:

in the am and then they have that they

Speaker:

actually have high cortisol in the pm and

Speaker:

they can't do wired retired.

Speaker:

And that's that's that kind of

Speaker:

dysregulated rhythm, it can play a big

Speaker:

role in affecting

Speaker:

thyroid function as well.

Speaker:

So I think that's why you have to look at

Speaker:

the whole picture from that perspective.

Speaker:

But to answer your question, it's very

Speaker:

important for us because if at the end of

Speaker:

the day, if you're if you're thyroid

Speaker:

hormone, it's kind of like the one of the

Speaker:

lowest hanging fruit, you know, and if

Speaker:

that's not optimized, then it's going to

Speaker:

affect your whole body's health and

Speaker:

longevity and your metabolic health,

Speaker:

metabolic health is the foundation of how

Speaker:

longevity really that's why that's why

Speaker:

GLP ones, you know, as much as I don't as

Speaker:

much as they have side effects and other

Speaker:

things with them, they're probably net

Speaker:

positive for society, you know, because

Speaker:

at the end of the day, they're proving

Speaker:

people's metabolic health.

Speaker:

And I think if anything, that's going to

Speaker:

help your metabolic health as just from

Speaker:

like a first principles perspective for

Speaker:

health, I think that's going to be a good

Speaker:

thing for your for everyone really.

Speaker:

Yeah, no, I do appreciate that because I

Speaker:

think, I mean, again, I, I, I don't think

Speaker:

we need we should we should need GLP ones

Speaker:

and everybody's very quick to sort of

Speaker:

throw them under the bus.

Speaker:

But as a society, I think they're an

Speaker:

incredibly useful intervention.

Speaker:

And of course, just from the their

Speaker:

ability to, as you say, modulate

Speaker:

metabolic health by way of obviously

Speaker:

improving blood sugar, but the obvious,

Speaker:

of course, they are starting to show

Speaker:

quite a lot of efficacy for off off label

Speaker:

as well for helping to control

Speaker:

individuals with issues

Speaker:

with MCAS and histamine, etc.

Speaker:

So I do think that they're an incredibly

Speaker:

useful class of molecules.

Speaker:

Dr.

Speaker:

Kahn, I know we're sort of slowly

Speaker:

starting to run up in time, but I'd love

Speaker:

to ask you about mini circle and its

Speaker:

inability and its ability to help

Speaker:

regulate testosterone levels.

Speaker:

Now, the way I understand it, mini

Speaker:

circle, it's, it's, I suppose,

Speaker:

fundamentally, it's a

Speaker:

gene editing system.

Speaker:

And yeah, you're not directly editing the

Speaker:

genes, of course, but you're all

Speaker:

introducing a viral vector or you're

Speaker:

utilizing CRISPR or anything like that.

Speaker:

But from what I understand, you're

Speaker:

utilizing a sort of a plasma vector, a

Speaker:

plasmid vector, I think, to then alter

Speaker:

the expression of various genes.

Speaker:

I've bring this full circle, of course,

Speaker:

could you sort of explain that process to

Speaker:

us and how you're utilizing it to help

Speaker:

optimize testosterone

Speaker:

levels in individuals?

Speaker:

Yeah, so it's what's

Speaker:

called an additive gene therapy.

Speaker:

So we're adding a gene to your body,

Speaker:

we're not editing your genes.

Speaker:

So it's, it's obviously safer in that

Speaker:

sense, because it's not as complicated.

Speaker:

But and traditionally, the problem with

Speaker:

gene therapy, additive gene therapy was,

Speaker:

you know, finding the right vector that

Speaker:

could be both safe and effective.

Speaker:

Mini circle plasmids are definitely very

Speaker:

safe, because they're very inert.

Speaker:

So they're basically derived from

Speaker:

bacteria from E. coli is kind of just

Speaker:

imagine it just like the name says, it's

Speaker:

a mini circle, it's like

Speaker:

a little circle of DNA.

Speaker:

And then you can you can use it to what's

Speaker:

called transfect a cell.

Speaker:

So that cell becomes like a little

Speaker:

factory to produce more

Speaker:

of the gene of interest.

Speaker:

So that gene of interest could be could

Speaker:

be like something for helping with

Speaker:

muscle, it could be something to help

Speaker:

with brain could be there's so many

Speaker:

different genes, obviously.

Speaker:

And the one that became that we've been

Speaker:

doing is something called follow statin,

Speaker:

which is more to help

Speaker:

with muscle strength.

Speaker:

And interestingly,

Speaker:

just to share my experience with people,

Speaker:

the mini circle plasmid has kind of been

Speaker:

like hit or miss, you know, it works for

Speaker:

some people, it doesn't work for others.

Speaker:

So it's not consistent.

Speaker:

But there is something called, there's a

Speaker:

company called triple helix, which has

Speaker:

what's called a viral gene

Speaker:

therapy, a AV, adeno, socio virus.

Speaker:

And that one has, you know, a V's have

Speaker:

been studied for decades.

Speaker:

And the issue historically with viral

Speaker:

vectors was triggering some sort of

Speaker:

immune response, right?

Speaker:

Like you don't want your

Speaker:

immune system to attack the virus.

Speaker:

But now they can engineer the viruses, so

Speaker:

they're hypo immune, and they don't have

Speaker:

that risk with them.

Speaker:

So essentially, you can transfect the

Speaker:

cells with this viral vector.

Speaker:

And it does work more

Speaker:

effectively than the mini circle.

Speaker:

I you know, in terms of safety, it's also

Speaker:

it based off their data, it seems to

Speaker:

equally as safe too.

Speaker:

And it can last.

Speaker:

The interesting thing about the viral

Speaker:

vector is it can last for up to 10 years.

Speaker:

Whereas you know, the mini

Speaker:

circle only lasts for a year.

Speaker:

So there's some

Speaker:

interesting pros and cons of each.

Speaker:

But the point is, these vectors, whether

Speaker:

it's a viral vector or a mini circle

Speaker:

vector, they can eventually be used to

Speaker:

transfect your G your cells to perhaps

Speaker:

produce more kisspeptin or luteinizing

Speaker:

hormone or gene or H.

Speaker:

Yeah, yeah, something to help your body

Speaker:

produce more

Speaker:

testosterone for as an example.

Speaker:

So I think there's definitely going to be

Speaker:

interesting applications.

Speaker:

I know, I know mini circle, they were

Speaker:

trying to produce an LH gene therapy.

Speaker:

That was one of the things but they

Speaker:

couldn't get the levels high enough to

Speaker:

the test for the testosterone to actually

Speaker:

go high enough for it to be meaningful.

Speaker:

So it might not be a thing with mini

Speaker:

circle, maybe it'll be something with the

Speaker:

viral vector company.

Speaker:

But there's you know, this is obviously a

Speaker:

hot area and there's so

Speaker:

many companies in this space.

Speaker:

But I do think it's not that far distant

Speaker:

in the future, well, we'll have a gene

Speaker:

therapy product for hormone replacement

Speaker:

therapy as opposed to having to go on

Speaker:

like TRT or something.

Speaker:

Yeah, I suppose that is dependent on how

Speaker:

effectively the testicles or potentially

Speaker:

the theca cells and women, I think that's

Speaker:

where testosterone is produced in the

Speaker:

ovaries, are functioning as well.

Speaker:

I assume if somebody has

Speaker:

a secondary hypogonadism, something like

Speaker:

this would be effective if it's helping

Speaker:

to stimulate the HPT-8 to

Speaker:

then produce more testosterone.

Speaker:

But if there's a primary defect in the

Speaker:

tissue within the body, whether it's the

Speaker:

theca cells and women or I suppose

Speaker:

potentially the adrenal cells and women,

Speaker:

which obviously produces a certain amount

Speaker:

of androgens as well, or the testes and

Speaker:

men, that treatment like this is

Speaker:

assumedly not going to be as effective.

Speaker:

Would I be correct in my thinking there?

Speaker:

No, yeah, exactly.

Speaker:

It definitely will depend on the person

Speaker:

and their bodies, like let's say receptor

Speaker:

sensitivity and ability to kind of have

Speaker:

the signal because at the end of the day,

Speaker:

this is just introducing an additional

Speaker:

signal to your body,

Speaker:

which is this peptide, right?

Speaker:

And how receptive your body is to that

Speaker:

signal is going to really dictate whether

Speaker:

or not it functions well.

Speaker:

Yeah, no, definitely.

Speaker:

Again, Dr.

Speaker:

Kahn, I want to be

Speaker:

respectful of your time.

Speaker:

So I'd love to sort of end off with a few

Speaker:

rapid fire questions,

Speaker:

rapidish fire questions.

Speaker:

They're never rapid fire, but we can try.

Speaker:

We can try.

Speaker:

We can try.

Speaker:

In any case, okay, so yeah, and these are

Speaker:

going to be a bit all over the place.

Speaker:

Obviously, definitely with the focus on

Speaker:

the regenerative side of things.

Speaker:

But okay, so money, no object, and

Speaker:

someone comes to you and they're sort of

Speaker:

growth hormone deficient.

Speaker:

Are you sort of a fan of sort of Incrolex

Speaker:

or sort of HGH as sort of as a primary

Speaker:

replacement therapy there?

Speaker:

I guess it depends

Speaker:

how deficient they are.

Speaker:

But if they're on just like, let's say,

Speaker:

the low side of normal, which is like, I

Speaker:

would say, typical people as they get

Speaker:

older, then I'm

Speaker:

potentially a bit I'm a bigger fan.

Speaker:

I mean, maybe I'm a little bit biased of

Speaker:

growth hormone peptides.

Speaker:

So for example, like I from relevant and

Speaker:

test from rally and then, you know, the

Speaker:

growth hormone releasing hormones and

Speaker:

trying to get your own body to produce

Speaker:

more of the peptide of

Speaker:

the hormone on its own.

Speaker:

So that's that's personally my approach.

Speaker:

But I know there are very good

Speaker:

endocrinologists and very some very good

Speaker:

doctors who know how to cycle, you know,

Speaker:

who know how to dose the GH properly and

Speaker:

pulse it and everything so that it

Speaker:

doesn't cause your own body to shut down

Speaker:

or anything like that.

Speaker:

Yeah, no, I think that's

Speaker:

definitely the smart way forward.

Speaker:

And sadly, I think for a lot of people,

Speaker:

again, as the age, you're going to

Speaker:

struggle with the production, you're

Speaker:

going to struggle to get the maturity to

Speaker:

reduce enough GH, obviously,

Speaker:

which I think is maybe where those

Speaker:

peptides start to lose the efficacy.

Speaker:

As one gets older, would I

Speaker:

be correct my thinking there?

Speaker:

The your body's own the secret to dogs?

Speaker:

Yeah, you're yes.

Speaker:

Yeah, because you mean that because the

Speaker:

pituitary signal wouldn't be as good as

Speaker:

it was when you're younger?

Speaker:

Yeah, essentially.

Speaker:

Yeah, so so that yeah, so

Speaker:

they may not be as effective.

Speaker:

But then I mean, I've been able to use

Speaker:

those peptides and people in their 60s,

Speaker:

even, you know, to help them with their

Speaker:

growth hormone and fat loss

Speaker:

and recovery and all that stuff.

Speaker:

Okay, that's amazing.

Speaker:

Okay, next one, cloth or follow statin

Speaker:

just from a sort of a longevity

Speaker:

regenerate standpoint,

Speaker:

which sort of big stats you both

Speaker:

know is kind of the brain, let's say the

Speaker:

brain one, right helps it can help with

Speaker:

brain focus, like may help with IQ even

Speaker:

and has all these interesting benefits

Speaker:

for protect your body against dementia,

Speaker:

especially even if you have the apo E4

Speaker:

gene, it can protect your body.

Speaker:

So clotho is a really

Speaker:

interesting peptide.

Speaker:

And false data is kind of the physical

Speaker:

version of that, which it can help with

Speaker:

strength and muscle.

Speaker:

So I'm a little bit biased, I guess,

Speaker:

because I'm a bit of a gym guy.

Speaker:

And I think I think follow statin

Speaker:

probably has more applicability for the

Speaker:

wide, let's say the wider population

Speaker:

based intervention, because most people

Speaker:

don't have enough muscle, and most people

Speaker:

lose a lot of muscle as they get older.

Speaker:

So if you can do something to combat that

Speaker:

process, I think that's going to be a

Speaker:

more important public

Speaker:

health intervention.

Speaker:

Fair enough.

Speaker:

Okay, if you were to speculate, when do

Speaker:

you think gene therapy generally speaking

Speaker:

is going to go mainstream?

Speaker:

Do you think it's going to

Speaker:

be the next five 10 years?

Speaker:

Mainstream gene therapy is kind of I

Speaker:

think gene therapy is where like, you

Speaker:

know, stem cells were like 10 years ago,

Speaker:

maybe so like, yeah, 10 years probably

Speaker:

like stem cells, I mean, aren't

Speaker:

mainstream mainstream, but they kind of

Speaker:

are getting mainstream, you know, like,

Speaker:

obviously, like now with the big

Speaker:

celebrities and all these other people

Speaker:

doing it, there's a lot

Speaker:

of people interested in it.

Speaker:

And most people have heard about stem

Speaker:

cells, but most people have not heard

Speaker:

about gene therapy or like just have very

Speaker:

vague understanding of it.

Speaker:

Fair enough.

Speaker:

And last one, what is your longevity and

Speaker:

health optimization

Speaker:

routine currently look like?

Speaker:

Well, aside from just the basics of

Speaker:

weight training and cardiovascular, you

Speaker:

know, keeping the biggest thing I think

Speaker:

for that stuff is high intensity short

Speaker:

bursts of exercise, you don't have to

Speaker:

spend hours in the gym, you can even do

Speaker:

15 minutes of high intensity, like a full

Speaker:

body a few times a week, same thing with

Speaker:

high intensity interval training.

Speaker:

So I think being efficient and having

Speaker:

intelligent protocols is

Speaker:

kind of the way to do it.

Speaker:

And I think supplementation is also one

Speaker:

of those interesting areas, which we

Speaker:

could probably spend a

Speaker:

lot of time talking about.

Speaker:

But we were but I definitely like there's

Speaker:

certain supplements I definitely like

Speaker:

such as creatine, such as the collagen

Speaker:

peptide that you guys make, I really like

Speaker:

that one that we're talking about,

Speaker:

because that's, you know, something

Speaker:

that's hard to get through diet.

Speaker:

There's a really

Speaker:

interesting supplement called glitine.

Speaker:

Glitine is the only supplement I know

Speaker:

that can improve

Speaker:

intracellular glutathione.

Speaker:

So I like so that's a really interesting

Speaker:

supplement because glutathione is like

Speaker:

the master antioxidant in your body and

Speaker:

glitine can is

Speaker:

basically a precursor to that.

Speaker:

So those are some of like my favorite,

Speaker:

let's say, longevity supplements that I

Speaker:

take on a regular basis and then and then

Speaker:

just kind of doing the foundational stuff

Speaker:

with minimally processed foods and sleep

Speaker:

and mindfulness and all that good stuff.

Speaker:

That's amazing.

Speaker:

Dr.

Speaker:

Khan, you've been amazing.

Speaker:

Honestly, that was an

Speaker:

incredible conversation.

Speaker:

Thank you.

Speaker:

Where can we point people to find you

Speaker:

should they wish to sort of reach out

Speaker:

learn more about it and

Speaker:

what it is you do, etc.

Speaker:

Yeah, I mean, I think I'm most active on

Speaker:

Instagram at dr.acon aka jn.

Speaker:

And then we are web our company is called

Speaker:

Eterna, like eternal without L and our

Speaker:

website is Eterna.health if they want to

Speaker:

check it out for more information.

Speaker:

Perfect.

Speaker:

Thank you so much for your time.

Speaker:

I'm definitely going to have to sort of

Speaker:

try and get back into Mel's good books

Speaker:

and see if I can book

Speaker:

you again in the future.

Speaker:

But this has been amazing.

Speaker:

Thank you so much.

Chapters

Video

More from YouTube